IP Library Granted Patent US 10,067,149
Granted Patent B2
US 10,067,149 · App. 14/104,845 · Granted Sep 4, 2018

Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,067,149
App. No.
14/104,845
Granted
Sep 4, 2018
Kind
B2
Abstract

The present invention provides compositions and methods for detection and analysis of intracellular binding of a bioactive agent to a cellular target. In particular, provided herein are bioactive agents tethered to fluorophores, cellular targets fused to bioluminescent reporters, and methods of detecting and analyzing the interaction of bioactive agents with cellular targets therewith.

Claims (24)

1. A system comprising:

(a) a bioactive small molecule conjugated to a small molecule fluorophore;

(b) a cell that expresses a protein fusion of: (i) a protein of interest and (ii) a luciferase, wherein the bioactive small molecule is capable of binding non-covalently to the protein of interest upon interaction therewith, wherein the emission spectrum of the luciferase overlaps with the excitation spectrum of the small molecule fluorophore; and

(c) a substrate for the luciferase.

2. The system of claim 1 , wherein the small molecule fluorophore is a carboxy rhodamine analog.

3. The system of claim 1 , wherein the luciferase comprises a polypeptide with at least 70% sequence identity with SEQ ID NO.: 1.

4. The system of claim 1 , wherein the substrate for the luciferase is coelenterazine or a coelenterazine derivative.

5. The system of claim 4 , wherein the substrate is 2-furanylmethyl-deoxy-coelenterazine.

6. The system of claim 1 , wherein the bioactive small molecule conjugated to the small molecule fluorophore is within a cell.

7. The system of claim 1 , wherein the bioactive small molecule conjugated to the small molecule fluorophore is cell permeable.

8. The system of claim 1 , further comprising a permeabilization agent to potentiate entry of the bioactive small molecule conjugated to the small molecule fluorophore into the cell.

9. The system of claim 1 , wherein the bioactive small molecule conjugated to the small molecule fluorophore is part of a library of different bioactive small molecules tethered to fluorophores.

10. The system of claim 1 , wherein the protein fusion is one of a plurality of different proteins of interest fused to luciferase.

11. The system of claim 1 , wherein the bioactive small molecule is produced by non-natural chemical synthesis.

12. The system of claim 1 , wherein:

(i) said luciferase has a first emission spectrum with a first peak emission;

(ii) said small molecule fluorophore has an excitation spectrum that overlaps said first emission spectrum; and

(iii) said small molecule fluorophore has a second emission spectrum with a second peak emission, said second peak emission being substantially separated from said first peak emission.

13. The system of claim 12 , wherein substantially separated is at least 80 nm.

14. The system of claim 12 , wherein the Forster distance of the small molecule fluorophore and luciferase pair is less than 20 nm.

15. The system of claim 14 , wherein the Forster distance of the small molecule fluorophore and luciferase pair is less than 5 nm.

16. The system of claim 12 , wherein upon binding of the bioactive small molecule to the protein of interest, conversion of the substrate to a reaction product by the luciferase results in excitation of the small molecule fluorophore by BRET and fluorescence emission from the small molecule fluorophore.

17. The system of claim 1 , wherein upon binding of the bioactive small molecule to the protein of interest, conversion of the substrate to a reaction product by the luciferase results in excitation of the small molecule fluorophore by BRET and fluorescence emission from the small molecule fluorophore.

18. The system of claim 1 , wherein the protein of interest of the fusion protein is displayed on the cell surface or the protein of interest of the fusion protein is intracellular and the bioactive small molecule conjugated to a small molecule fluorophore is cell permeable.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2014
From: HITKO, CAROLYN W.; KIRKLAND, THOMAS; MACHLEIDT, THOMAS; OHANA, RACHEL FRIEDMAN; ROBERS, MATT; WOOD, KEITH
To: PROMEGA CORPORATION
Reel/Frame 032565/0933 →
Cited By (1)
US 12,606,863